UA101367C2 - Normal;heading 1;heading 2;heading 3;HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS - Google Patents

Normal;heading 1;heading 2;heading 3;HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS

Info

Publication number
UA101367C2
UA101367C2 UAA201013111A UAA201013111A UA101367C2 UA 101367 C2 UA101367 C2 UA 101367C2 UA A201013111 A UAA201013111 A UA A201013111A UA A201013111 A UAA201013111 A UA A201013111A UA 101367 C2 UA101367 C2 UA 101367C2
Authority
UA
Ukraine
Prior art keywords
heading
beta
normal
receptor agonists
adrenergic receptor
Prior art date
Application number
UAA201013111A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ричард Бергер
Лехуа Чан
Скотт Д. Эдмондсон
Стефен Д. Гобле
Соокхее Николь Ха
Нам Фунг Кар
Ихор Э. Копка
Бин Ли
Грегори Дж. Мориэлло
Крис Р. Мойз
Дун-Мин Шень
Липин Ван
Чен Чжу
Original Assignee
Мерк Шарп Енд Доме Корп.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Шарп Енд Доме Корп. filed Critical Мерк Шарп Енд Доме Корп.
Priority claimed from PCT/US2009/039249 external-priority patent/WO2009124166A1/en
Publication of UA101367C2 publication Critical patent/UA101367C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides compounds of Formula (Ia), pharmaceutical compositions thereof, and methods of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
UAA201013111A 2008-04-04 2009-04-02 Normal;heading 1;heading 2;heading 3;HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS UA101367C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12306308P 2008-04-04 2008-04-04
PCT/US2009/039249 WO2009124166A1 (en) 2008-04-04 2009-04-02 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

Publications (1)

Publication Number Publication Date
UA101367C2 true UA101367C2 (en) 2013-03-25

Family

ID=51585278

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201013111A UA101367C2 (en) 2008-04-04 2009-04-02 Normal;heading 1;heading 2;heading 3;HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS

Country Status (1)

Country Link
UA (1) UA101367C2 (en)

Similar Documents

Publication Publication Date Title
MX2012002366A (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists.
UA95644C2 (en) Pyridizinone derivative, pharmaceutical composition and treatment method
MA32257B1 (en) Hydroxymethyl pyrrolidines as agonists of beta-3 adrenergic receptors.
WO2008021851A3 (en) Novel compounds as antagonists or inverse agonists for opioid receptors
TNSN08373A1 (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
MX2011011661A (en) Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750.
IN2012DN02177A (en)
IN2012DN02730A (en)
IN2012DN00754A (en)
UA102251C2 (en) Aminidihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
MY150787A (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of prevention of diabetes
MX2009007337A (en) 5-pyridinone substituted indazoles.
JO2686B1 (en) compounds
UA96308C2 (en) Glucagon receptor antagonist compounds, composition comprising such compounds and use thereof
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
TW200740814A (en) Compounds
JO2645B1 (en) Compounds
TW200738659A (en) Novel compounds
UA98804C2 (en) Catecholamine derivatives and pharmaceutical composition based thereon
GB0611907D0 (en) Compounds
MX2008002805A (en) Carboxamide derivatives as muscarinic receptor antagonists.
UA96277C2 (en) Benzimidazole derivatives
GB0524814D0 (en) Compounds
MX2010009462A (en) Indazole derivatives.